Cartesian Therapeutics Inc (RNAC)

Investing Cash Flow

-$272.00K

Quarterly · Period ending: · USD

RNAC logo

RNAC Investing Cash Flow

Latest reported-$272.00K
RNAC Quarterly Cash from Investing (-$123.00K → -$272.00K)
High-resolution chart · PNG

RNAC investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cartesian Therapeutics Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-272,000
-27,000
-492,000
-1,292,000
-2,595,000
-1,075,000
-354,000
-6,199,000
-1,587,000
-602,000
6,497,000
0
-12,000
28,124,000
5,489,000
-29,937,000
-99,000
9,545,000
9,722,000
-1,802,000
-2,615,000
-22,445,000
-166,000
-286,000
-154,000
-135,000
-9,000
11,512,000
4,845,000
-16,119,000
-374,000
6,016,000
18,685,000
945,000
6,107,000
-2,371,000
10,698,000
-16,532,000
-5,204,000
-20,210,000
6,869,000
-3,555,000
-2,909,000
-1,217,000
-430,000
-123,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.